Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler
NCT01593644
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Heart Disease
Interventions
DRUG:
adenosine + dipyridamole
Sponsor
Adenobio N.V